Treatment within the trial protocol was not associated with significant clinical benefit, although the study was underpowered and alternatie results cannot be excluded.

• 虽然该项研究存在不足，而且没有剔除其他可能结果，但是取自试验方案的治疗方法与取得的显著临床受益没有联系。